QIAGEN to Launch 3 New Sample Prep Instruments by 2026 for Lab Automation QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced plans to launch three new sample preparation…
ATED Therapeutics Develops Simple Blood Test for Parkinson’s ATED Therapeutics Ltd. has announced the development of a new, rapid diagnostic test for Parkinson’s disease. Created in collaboration with researchers at…
RHÖN-KLINIKUM Campus Bad Neustadt Opens New Geriatric Traumatology and Orthogeriatrics Unit The RHÖN-KLINIKUM Campus Bad Neustadt has inaugurated a new specialized treatment unit dedicated to geriatric traumatology and orthogeriatrics. Designed…
Vicarious Surgical Inc. a next-generation robotics technology company, announced that it received a notice from the New York Stock Exchange (NYSE) on April 10, 2025, regarding non-compliance with continued listing…
A revolutionary new test for the early detection of testicular cancer—the most common cancer among young men—is now available in the UK. Developed by Cambridge-based EDX Medical, the non-invasive “TC100”…
Harrow Expands Access to VEVYE® for Klarity-C Patients at $59 Per Bottle Harrow (Nasdaq: HROW), a leading eyecare pharmaceutical company in North America, has announced the expansion of its VEVYE®…
A recent survey by Croí, the Heart & Stroke Charity in Ireland, in collaboration with the Global Heart Hub (GHH), has uncovered a worrying lack of awareness about heart attack…
Five Good Friends, a leading Australian home care provider, has announced a major strategic investment from TPG, a global alternative asset management firm. The partnership will support the company’s continued…
Teladoc Health Unveils Next-Generation Cardiometabolic Health Program to Combat Chronic Disease Teladoc Health (NYSE: TDOC), a global leader in virtual healthcare, has announced the launch of its next-generation Cardiometabolic Health…
Study Finds K Health’s AI Recommendations Match Doctors’ in Accuracy K Health, a leading AI-driven primary care platform, recently revealed exciting results from a novel study demonstrating that its AI-powered…
ENHERTU® Approved in the EU for HER2-Low Metastatic Breast Cancer Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) announced the approval of ENHERTU® (trastuzumab deruxtecan) in the European Union (EU)…
eClinical Solutions: AI Adoption and Risk-Based Strategies in 2025 Clinical Trials eClinical Solutions LLC, a global provider of digital clinical software and services, has unveiled key insights from its 2025…
